Medical Health & Life Science Research News

The antibody drug conjugates market is set to experience revolutionary growth in near future

The antibody drug conjugates market is set to experience revolutionary growth in near future

Antibody drug conjugates (ADC’s) are promising and effective anticancer medications employed for efficient treatment of cancer patients.

- Advertising -

The antibody drug conjugates market was valued at $1,387 million in 2016, and is estimated to reach $3,198 million by 2023, registering a CAGR of 12.9% from 2017 to 2023.

ADC’s are biopharmaceutical drugs prepared by integrating two clinical approaches viz cell killing HPAPI (powerful pharmaceutical ingredient) and monoclonal antibody specificity. This combination approach enables elimination of cancer infected cells without harming healthy cells in patient’s body.

- Advertising -

Request for Sample [email protected] www.bigmarketresearch.com/request-sample/1548465

Increase in global prevalence of cancer and demand for quality & cost-effective cancer medications drives the global ADCs market. In addition, extensive R&D for cancer medication and approval of new cancer drugs is expected to boost the market growth during the forecast period.

However, high cost involved in R&D of cancer medication and stringent government regulations impedes the growth of antibody drug conjugates market.

The report segments the market based on drugs, mechanism of action, application, and region. Based on drugs, the market is bifurcated into Adcetris and Kadcyla.

Based on mechanism of action, it is divided into CD30 antibodies and HER2 antibodies. Based on application, the market is classified into breast cancer, lymphoma, and others.

By geography, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Enquire about [email protected] www.bigmarketresearch.com/purchase-enquiry/1548465

KEY BENEFITS FOR STAKEHOLDERS

  • The study provides an in-depth analysis of the market with current trends and future estimations to elucidate the imminent investment pockets.
  • It offers a quantitative analysis from 2017 to 2023, which is expected to enable the stakeholders to capitalize on prevailing market opportunities.
  • Extensive analysis by product elucidates the various types of ADC’s used for diverse cancer therapeutic procedures
  • Comprehensive analysis of all geographical regions is provided to determine the prevailing opportunities.
  • Key players are profiled and their strategies are analyzed thoroughly, which helps understand the competitive outlook of the global ADCs market.

News From

Big Market Research - Market Research ReportsBig Market Research
Category: Market Research Publishers and RetailersCompany profile: With the arsenal of different search reports, we help you here to look and buy research reports that will be helpful to you and your organization. Our research reports have the capability and authenticity to support your organization for growth and consistency. With the window of opportunity getting open and shut at a speed of light, it has become very important to survive in the market and only the fittest and competent enough can do so. So, we try and provide with latest changes in the market ...